Top 5 Global Health Headlines: India Rejects HIV Patent

Media Article 24 Jan 2011

PBS Newshour reports: The refusal to grant protection for Abbott means generic-drug companies can continue selling copies of the medication at a fraction of the price to the developing world.

Partner with us now to build
a more just and equitable
medicine system for all.